5-Hydroxytryptamine pathways in anxiety and its treatment.
about
Increased anxiety of mice lacking the serotonin1A receptorAnimal models for screening anxiolytic-like drugs: a perspectiveThe noradrenergic action in antidepressant treatments: pharmacological and clinical aspectsS 15535, a benzodioxopiperazine acting as presynaptic agonist and postsynaptic 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal scopolamineSerotonin circuits and anxiety: what can invertebrates teach us?The response of neurons in the bed nucleus of the stria terminalis to serotonin: implications for anxiety.Serotonergic function, two-mode models of self-regulation, and vulnerability to depression: what depression has in common with impulsive aggressionBrain mast cells link the immune system to anxiety-like behavior.Depression and anxiety in Parkinson's disease: possible effect of genetic variation in the serotonin transporter.The single dose pharmacokinetics and safety of deramciclane in healthy male volunteers.Serotonin, stress and corticoids.Opposing alterations in anxiety and species-typical behaviours in serotonin transporter overexpressor and knockout mice.Low doses of 8-OH-DPAT prevent the impairment of spatial learning caused by intrahippocampal scopolamine through 5-HT(1A) receptors in the dorsal raphe.Why do some individuals develop social phobia? A review with emphasis on the neurobiological influences.Modulation of anxiety circuits by serotonergic systems.Differential control of cardiac and sympathetic vasomotor activity from the dorsomedial hypothalamus.A comparison of the subsecond dynamics of neurotransmission of dopamine and serotoninRegulation of extracellular serotonin levels and brain-derived neurotrophic factor in rats with high and low exploratory activityTriple reuptake inhibitors as potential next-generation antidepressants: a new hope?Bi-directional modulation of bed nucleus of stria terminalis neurons by 5-HT: molecular expression and functional properties of excitatory 5-HT receptor subtypes.MDMA pretreatment leads to mild chronic unpredictable stress-induced impairments in spatial learning.Neurochemical and behavioural effects of hypidone hydrochloride (YL-0919): a novel combined selective 5-HT reuptake inhibitor and partial 5-HT1A agonist.Effect of Cissampelos Pareira Leaves on Anxiety-like Behavior in Experimental Animals.Absence of sibutramine effect on spontaneous anxiety in rats.Neuropeptide S selectively inhibits the release of 5-HT and noradrenaline from mouse frontal cortex nerve endings.Onset and early behavioral effects of pharmacologically different antidepressants and placebo in depression.The role of genetic variability in the SLC6A4, BDNF and GABRA6 genes in anxiety-related traits.A single dose of mirtazapine attenuates neural responses to self-referential processing.Stimulation of 5-HT1A receptors in the dorsal raphe reverses the impairment of spatial learning caused by intrahippocampal scopolamine in rats.Midbrain volume increase in patients with panic disorder.Chronic unpredictable stress induces a cognitive deficit and anxiety-like behavior in rats that is prevented by chronic antidepressant drug treatment.The loudness dependence of the auditory evoked potential (LDAEP) as a predictor of the response to escitalopram in patients with generalized anxiety disorder.
P2860
Q24655613-EE2B94DD-1F66-42D6-9ECF-9B1FD7C21B93Q26781104-0843D987-2750-4BEC-A6E7-192BA22BF6BDQ28300843-D948399C-0817-42A3-9F81-33E136E59449Q28343737-B7B2E403-2468-4867-AAF1-80C2CA51C5E8Q28485318-3842F5FF-530C-457A-967E-80011063F7B2Q30478694-276246DB-C24F-4A10-92D8-6C2CFF234903Q30482466-A2FCDFD7-5428-4275-8B86-7B412768D99AQ30484650-911F3EC9-90E9-4665-9CDE-205520B997D7Q33873790-F49D0549-40F0-4132-A1F1-EC057CADDB47Q33897835-091E9FAB-B0F8-4DF8-BBDD-C0C43116B0B1Q33965272-0FB1465B-4475-49F4-8466-3BBD42886EC5Q34571034-D9E80CC5-6163-4299-A585-A4579C0E3F40Q35042705-90C27A2A-908B-4246-AF62-D1110A9AED02Q35888987-52C7B0B4-22CA-4CC6-BD1F-46E327664DC3Q36372784-AE0E95B9-2528-4224-96A3-AD35EEC6F555Q36690388-D3D5BBA4-1458-4FA7-AF8B-71FF722A91DDQ36851718-1C6E0F38-AE93-4772-9AF2-1E03E1B12D97Q36940308-C7B67EFF-B799-42B0-8571-6993128B13C1Q37158450-6545E77B-8C85-48D5-AC44-97D9DF58BC75Q37440533-FBC91D5D-75A5-4766-9384-E01BD38C25E4Q37452207-A75FEA00-532E-430A-AA5D-C8CD2FBBFC1DQ39157204-4A4E6572-D0CA-4244-ACDD-BCC0D41A1034Q41956474-00FA6E84-6428-4444-8519-503CEB001D0EQ42972169-91CD4750-F99C-47C7-AB96-E92354CD28DBQ43097962-0BA3C820-F014-4D21-AC05-A4B11C6B65D6Q44662293-F8A904F6-250B-43B1-908C-A1EF29ECE854Q47267712-BF769D2D-1335-4D37-A8AE-70398CEBFC3DQ47619385-1F48B413-DA54-4574-BD0D-3BE5A70F83DBQ48387097-7EA537D5-AC92-4946-B43B-58F1D0A8FE39Q49158083-60C8FADE-715F-4C42-A592-583952410CC3Q50905174-72F0E8E3-415A-40D1-9EA2-C0CE22E15EFAQ53451856-3C67DA2A-742B-4507-8138-C3F7017CF69B
P2860
5-Hydroxytryptamine pathways in anxiety and its treatment.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
5-Hydroxytryptamine pathways in anxiety and its treatment.
@en
type
label
5-Hydroxytryptamine pathways in anxiety and its treatment.
@en
prefLabel
5-Hydroxytryptamine pathways in anxiety and its treatment.
@en
P1476
5-Hydroxytryptamine pathways in anxiety and its treatment.
@en
P2093
Handley SL
P304
P356
10.1016/0163-7258(95)00004-Z
P577
1995-04-01T00:00:00Z